University College London | PharmaTimes

UCL researchers launch congenital muscular dystrophy research programme

Emily Kimber — Wed, 23 Apr 2025 11:16:58 +0000

The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK

Jen Brogan — Mon, 12 Aug 2024 10:00:00 +0000

Bowel cancer was the most common cancer to be identified in both men and women

Jen Brogan — Fri, 09 Aug 2024 09:59:00 +0000

In the UK, there are an estimated 11 million people living with a neurological condition

Jen Brogan — Wed, 07 Aug 2024 10:00:00 +0000

Researchers aim to explore and investigate axonal dysfunction in neurodegeneration

Jen Brogan — Fri, 26 Jul 2024 10:20:15 +0000

Researchers predicted the onset of 67 diseases, out-performing current standard models

Jen Brogan — Thu, 25 Jul 2024 10:28:54 +0000

The research will help to better understand how this pathway is coordinated in the cell

Jen Brogan — Wed, 24 Jul 2024 10:10:06 +0000

The neurodegenerative disease is currently the most common cause of dementia

Jen Brogan — Thu, 18 Jul 2024 09:59:00 +0000

Genentech’s Pulmozyme could also treat other respiratory infections and conditions

Jen Brogan — Wed, 10 Jul 2024 10:00:34 +0000

The neurodegenerative condition currently affects more than 944,000 people in the UK

Jen Brogan — Wed, 03 Jul 2024 09:55:45 +0000

Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK